Investment Terms Summary

• Issuer: Hungry Pets SA (Crokeo)
• Instrument: Equity / Investment Round
• Total Raise: CHF 450'000
• Minimum Ticket: To be defined
• Maturity / Conversion: N/A (Direct Equity Investment)
• Investor Eligibility: Professional / Qualified Investors
• Use of Proceeds: Phase 1 CAPEX (production kitchen setup in Chavornay, Shopify live), team & sales runway to break-even, non-recurring expenses (HACCP, R&D, certifications), and Phase 2 reserve buffer.

Opportunity Overview

Hungry Pets SA (Crokeo) is a Swiss-based pet food pioneer capturing a massive market gap: fresh, human-grade pet food with a retail-ready shelf life. While the European fresh pet food segment has reached a 17% penetration rate, Switzerland lags at <2% due to strict regulations and a lack of local preservation infrastructure.

By leveraging High-Pressure Processing (HPP) cold pasteurization at 6,000 bar, Crokeo delivers a refrigerated shelf life of 5–6 months without heat treatment or artificial preservatives, retaining over 90% of natural nutrients. This technological edge completely eliminates the need for an expensive frozen supply chain, unlocking multi-channel distribution across Direct-to-Consumer (D2C) subscriptions, vet clinics, and traditional retail. Supported by key strategic partnerships (HPP Competence SA for processing and Fenaco for raw ingredient sourcing), Crokeo holds an 18–24 month first-mover advantage in a premium Swiss market projected to reach CHF 1B by 2033.

Traction Highlights

• Validated Demand: 8,000+ fresh meals sold during the initial pilot phase.
• Existing Ecosystem: 750+ active Crokeo Dry subscribers generating CHF 55k MRR, providing an immediate organic cross-sell pipeline with exceptional unit economics (11:1 LTV:CAC).
• Strategic B2B Go-To-Market: Swissvet Group and MeikoVet are already onboarded as investors and distribution partners, securing immediate veterinary-channel credibility.
• Capital-Efficient Scale: Blended gross margins of ~50% (61.3% D2C) driving EBITDA profitability by Month 13, scaling revenue from CHF 91k (Y1) to CHF 15M (Y5) for a projected ~8% market share.

Disclaimer

This document is for informational purposes only and does not constitute an offer to sell or solicitation of an offer to purchase securities. Investments in early-stage companies involve risk, including possible loss of capital. Ful l legal documentation governs the investment.

The PowerPoint presentation file will be accessible after the pre-booking req uest.